MEXICO CITY, June 2, 2023 /PRNewswire/ — Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) (“Genomma Lab” or “the Company”), one of the leading pharmaceutical and personal care product companies in Mexico with an expanding international presence, informs that the Company filed a Notice of Rights with the Mexican Stock Exchange (Bolsa Mexicana de Valores) declaring a … Read more
Six médicaments développés par Dragonfly sont actuellement en clinique. WALTHAM, Massachusetts, 2 juin 2023 /PRNewswire/ — Dragonfly Therapeutics, Inc., a annoncé aujourd’hui avoir élargi son équipe de direction clinique en y intégrant le Dr Robin Edwards, anciennement directeur mondial des sciences translationnelles chez Daiichi Sankyo et directeur des sciences translationnelles chez Bristol Myers Squibb, et … Read more
Kisqali is the first and only CDK4/6 inhibitor to demonstrate a consistent, clinically meaningful benefit across a broad population of patients with HR+/HER2- early breast cancer, regardless of disease stage, menopausal or nodal status1 Results were also consistent across all secondary endpoints, including distant disease-free survival and recurrence-free survival, with a trend for improved overall … Read more
Stephen P. MacMillan, Hologic CEO, named non-executive Chair of Illumina’s Board Scott B. Ullem, CFO of Edwards Lifesciences, also named to Board SAN DIEGO, June 2, 2023 /PRNewswire/ — Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced a series of governance changes consistent with the goal of enhancing long-term … Read more
Mitra® et hemaPEN® reçoivent la certification réglementaire en tant que dispositifs médicaux pour le prélèvement d’échantillons sanguins à distance dans les soins de santé, les essais cliniques et les programmes de surveillance à domicile en Europe et au Royaume-Uni. MELBOURNE, Australie, 2 juin 2023 /PRNewswire/ — Trajan Scientific and Medical, l’un des principaux fournisseurs de … Read more
— Dr. Loew to Assume New Leadership Role Upon Completion of the Planned Separation of Alkermes’ Oncology Business — — Planned Separation Remains on Track to be Completed in Second Half of 2023 — DUBLIN, June 1, 2023 /PRNewswire/ — Alkermes plc (Nasdaq: ALKS) today announced that Caroline J. Loew, Ph.D., has been appointed as the … Read more
DUBLIN, June 1, 2023 /PRNewswire/ — The “Peptide Therapeutics Global Market Report 2023” report has been added to ResearchAndMarkets.com’s offering. This report provides strategists, marketers and senior management with the critical information they need to assess the market. The global peptide therapeutics market grew from $37.26 billion in 2022 to $40.7 billion in 2023 at a … Read more
~Jaime Herrera Beutler of Clark County, Washington joins the fight against kidney disease ~ NEW YORK, June 1, 2023 /PRNewswire/ — The National Kidney Foundation (NKF) is excited to announce the appointment of Jaime Herrera Beutler, former U.S. Congresswoman and Washington state legislator, to its National Board of Directors. Herrera Beutler was nominated and approved at NKF’s … Read more
Hours before going into effect today, UnitedHealthcare rightly stopped its draconian prior authorization policy that would have forced its 27.4 million commercial beneficiaries to wait for time-sensitive endoscopy services, increasing the risk of disease progression, deferred care, and cancers going undetected However, the temporary patch UHC has imposed instead lays the groundwork for prior authorization … Read more
Through the Medicare and Medi-Cal funded Program of All-Inclusive Care for the Elderly (PACE), WelbeHealth delivers fully integrated care that allows seniors to age in place Both new locations are poised to meet the needs of an aging population across greater metro LA; thousands of residents local to the new centers are over 55 and … Read more